Alnylam Pharmaceuticals to Webcast Presentation at Upcoming Investor Conferences
Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, today announced that management will present a company overview at the 15th Annual BIO CEO & Investor Conference on Tuesday, February 12, 2013 at 2:30 p.m. ET at the Waldorf Astoria in New York City.